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Assessment of Intermediate Severity
Coronary Lesions in the Catheterization Laboratory
Jonathan Tobis, MD, Babak Azarbal, MD, Leo Slavin, MD
Los Angeles, California
The management of intermediate coronary lesions, defined by a diameter stenosis of 40% to 70%, continues to
be a therapeutic dilemma for cardiologists. The 2-dimensional representation of the arterial lesion provided by
angiography is limited in distinguishing intermediate lesions that require stenting from those that simply need
appropriate medical therapy. In the era of drug-eluting stents, some might propose that stenting all intermediate
coronary lesions is an appropriate solution. However, the possibility of procedural complications such as coro-
nary dissection, no reflow phenomenon, in-stent restenosis, and stent thrombosis requires accurate stratification
of patients with intermediate coronary lesions to appropriate therapy. Intravascular ultrasound (IVUS) and frac-
tional flow reserve index (FFR) provide anatomic and functional information that can be used in the catheteriza-
tion laboratory to designate patients to the most appropriate therapy. The purpose of this review is to discuss
the critical information obtained from IVUS and FFR in guiding treatment of patients with intermediate coronary
lesions. In addition, the importance of IVUS and FFR in the management of patients with serial stenosis, bifurca-
tion lesions, left main disease, saphenous vein graft disease, and acute coronary syndrome will be discussed.
(J Am Coll Cardiol 2007;49:839–48) © 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.10.055i
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tn intermediate coronary lesion on angiography is defined
s a luminal narrowing with a diameter stenosis 40% but
70%. Assessment of a coronary lesion with intermediate
everity continues to be a challenge for cardiologists. In the
urrent era of drug-eluting stents (DES), when percutane-
us coronary revascularization is achieved with high success,
low complication rate, and excellent long-term patency
1,2), it might be tempting to treat all suspect lesions with
mplantation of a DES. However, there are still procedural
omplications associated with angioplasty, the inherent risk
f restenosis, and late stent thrombosis.
Although it is preferable to have objective evidence of
yocardial ischemia before proceeding with percutaneous
oronary revascularization, this is not always feasible or
ompletely reliable. Selective coronary angiography is ac-
epted as the standard for determining the presence and
xtent of epicardial coronary artery disease (CAD). All
easures of noninvasive assessment of myocardial ischemia
re compared with the presence on angiography of a focal
tenosis 50% diameter. This cutoff is based on animal
tudies and human clinical correlations that demonstrate
unctional significance (the induction of ischemia) with the
natomic presence of a 50% diameter stenosis (3). However,
here is significant interobserver and intra-observer variabil-
ty in interpretation of the severity of stenoses on coronary
ngiography (4–6). In addition, cross-sectional anatomic
rom the David Geffen School of Medicine at UCLA, Department of Medicine
Division of Cardiology), Los Angeles, California.o
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ccepted October 16, 2006.maging obtained from histopathological specimens (7–11)
nd intravascular ultrasound (IVUS) (12–15) have high-
ighted limitations of coronary angiography. Owing to the
ncreased sensitivity of IVUS in identifying disease and its
lose correlation with pathology, IVUS has become the
ore accurate standard for defining the anatomy of athero-
clerosis in vivo.
There are 2 methods available in the cardiac catheteriza-
ion laboratory to determine the physiologic significance of
coronary stenosis that are distinct from the anatomic
isualization provided by IVUS. These methods rely on the
ecrease in intra-arterial pressure or flow induced by a
unctionally significant stenosis to determine whether an
ntermediate lesion is producing ischemia. At the current
ime, coronary pressure wire-derived fractional flow reserve
FFR) has supplanted Doppler wire-derived coronary flow
eserve (CFR) as the preferred method to assess the phys-
ologic significance of a coronary stenosis.
This review will discuss the challenges involved in the
ssessment and management of a patient with an interme-
iate lesion. It will focus on the 2 most commonly used
ethods for assessment of intermediate coronary lesions:
VUS and FFR (Table 1).
imitations of Angiography
istopathological studies have demonstrated that angio-
raphic evidence of stenosis is usually not detected until the
ross-sectional area of plaque approaches 40% to 50% of
he total cross-sectional area of the vessel (16–18). The
uter wall of the artery, encompassed by the external
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larges to accommodate the grow-
ing plaque. This process of com-
pensatory dilatation seems to be
limited. When the plaque area
exceeds 40% to 50% of the EEM
area, the plaque begins to en-
croach upon the lumen. It is only
then that an angiogram might
reveal minimal luminal narrow-
ing (19,20). A minority of angio-
graphic stenoses might develop
by a process of narrowing of the
EEM without the presence of a
large amount of plaque, a process
called negative remodeling (21,22).
Similar to a low power histo-
logic cross section, IVUS can
identify the presence and extent
of plaque and the area of the
EEM in vivo, thereby making it
more sensitive than angiography
(7–12,14,15,17,23). In addition,
angiography provides only limited
information regarding the compo-
sition of the coronary plaque or the
degree of calcification (17,24–26).
imilar to a flashlight projection of a tube in 3-dimensional
pace, an angiogram is a 2-dimensional X-ray projection of the
rterial lumen along the length of the vessel. Stenoses might be
ncorrectly assessed owing to tortuosity or angulation of the
Abbreviations
and Acronyms
ACS  acute coronary
syndrome
AMI  acute myocardial
infarction
CAD  coronary artery
disease
CFR  coronary flow
reserve
DES  drug-eluting stent
EEM  external elastic
membrane
FFR  fractional flow
reserve
IVUS  intravascular
ultrasound
MACE  major adverse
cardiovascular event
PCI  percutaneous
coronary intervention
SPECT  single-photon
emission computed
tomography
SVG  saphenous vein
graft
omparison of IVUS WithFR in Specific Lesion Subsets
Table 1 Comparison of IVUS WithFFR in Specific Lesion Subsets
IVUS FFR
Native CAD MLD 1.8 mm 0.75–0.8
MLA 4.0 mm2
Left main MLD 2.8 mm 0.75
MLA 5.9 mm2
Serial lesions Assesses anatomic severity
along the length of the
artery
Relative contribution of
each stenosis on
pullback method
SVG Identifies severe lesion and
tissue characteristics.
Helps identify when to
use distal protection
device
No data for FFR in SVG;
data correlating
rCFR with SPECT
available
Ostial lesions Helps locate ostial-aorta
juncture and correct
stent position
0.75
Acute MI Demonstrates plaque
burden
Limited data
Bifurcation lesions Assesses size of main and
side branch, adequacy
of results
0.75
AD  coronary artery disease; FFR  fractional flow reserve; IVUS  intravascular ultrasound;
I  myocardial infarction; MLA  minimum lumen area; MLD  minimum lumen diameter;n
CFR  relative coronary flow reserve; SPECT  single-photon emission computed tomography;
VG  saphenous vein graft.essels, artery overlap, a short “napkin-ring stenosis,” X-ray
eam angulation that is not perpendicular to the stenosis, or
ontrast streaming or separation as it enters an ectatic area. The
xtent of stenosis is judged by comparison with a reference
egment that theoretically is free of disease. However, the
eference segment itself often has significant disease as dem-
nstrated by histopathology or IVUS (26). In addition, signif-
cant intra- and inter-observer variability exists in the assess-
ent of coronary stenoses (27). Although the advent of
uantitative coronary angiography (QCA) has reduced inter-
bserver variability, it has not improved the accuracy of
oronary angiography to determine the severity of coronary
esions.
VUS
ntravascular ultrasound is a catheter-based technique that
rovides tomographic images perpendicular to the length of
he coronary arteries. High-resolution cross-sectional images
f the coronary lumen and the coronary arterial wall can be
isualized in real time, and computer-generated reconstruction
llows for longitudinal and 3-dimensional visualization of the
oronary artery (Fig. 1). Intravascular ultrasound is simple to
erform, and its use is associated with very low complication
ates (28), even in the setting of acute myocardial infarction
AMI) (29).
Intravascular ultrasound can segregate lesions according to
hether they appear stable versus unstable on the basis of the
ltrasound grayscale reflectance of the tissue (30). Stable
laques have more fibrous tissue or calcification, whereas an
nstable plaque has mobile echoes consistent with thrombus or
ecrotic material and usually is associated with large atheroma
30). The presence of a plaque with an echolucent central core
nd a thin fibrous capsule, the so-called “vulnerable plaque,”
an also be identified by IVUS. Whether these lesions should
e treated by percutaneous coronary intervention (PCI)
ersus medical therapy has not been elucidated by clinical
rials.
The advent of radiofrequency signal analysis and elastogra-
hy techniques might in the future provide incremental clinical
nformation regarding the exact histologic composition of
therosclerotic plaques and possibly their vulnerability to rup-
ure (31); however, there is no convincing evidence that
o-called “virtual histology” adds any information beyond the
raditional IVUS grayscale image, and it could be misleading.
Despite the elaborate anatomic information provided by
VUS, there are some technical limitations, including the
nability to deliver the catheter to the region of interest in
ortuous vessels, through high-grade or calcified stenoses,
nd in smaller epicardial arteries. Other limitations
nclude non-uniform rotational distortion (NURD) with
echanical IVUS transducers and distortion of the cross-
ectional image if the IVUS catheter image plane is not
erpendicular to the long axis of the vessel (32). Unlike
-dimensional transthoracic echocardiography, there is
o phased array IVUS device. The closest approximation
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nd multiplex transistors at the catheter tip. Because there is
o mechanically rotating device shaft, the synthetic aperture
ltrasound catheter passes over the wire through a central
umen. This facilitates maneuvering the catheter through
ore torturous anatomy. However, this benefit of ease of
se comes with a consequence of lower power and inferior
Figure 1 Intermediate Lesion That According to an Expert Pane
Intervention on the Basis of the Images Attained From
(A) A coronary angiogram that shows an intermediate lesion in the mid-left anterio
case was presented during an international live case presentation conference with
cardiologists whether this angiogram represented a significant stenosis. There we
(B) Intravascular ultrasound (IVUS) imaging was performed. Representative cross-s
dimension of the lumen was 4.7 mm2. (Right) The IVUS image proximal to the bif
bifurcation with the diagonal branch. Fractional flow reserve (FFR) was also perform
angiogram, on the basis of the IVUS images and FFR, no intervention was performmage quality. eFR
lood flow as volume/time cannot be measured directly in
umans in the catheterization laboratory. The concept of CFR
as introduced in the 1970s and is based on the principle that
lood velocity is proportional to volume flow if the lumen area
emains constant. The CFR is defined as the ratio of hyper-
quires an
onary Angiography
ending artery (LAD) just distal to the bifurcation with the diagonal branch. This
el of 8 renowned interventional cardiologists. There was no accord among the
icting recommendations whether to perform coronary angioplasty in the LAD.
al IVUS images are shown. (Left) At the greatest area of stenosis, the smallest
n. (Middle) The IVUS cross-sectional image of the mid-LAD at the level of the
d was measured at 0.85. Contrary to the panel’s suggestions based on thel Re
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Assessment of Intermediate Coronary Lesions February 27, 2007:839–48oronary artery (3,33). The CFR decreases with increased
esion severity (34). Doppler-derived CFR measurements have
een validated in the assessment of lesion severity, and a CFR
alue of 2.0 has been found to identify a hemodynamically
ignificant stenosis (35–39).
Unfortunately, the CFR value is affected by both epicar-
ial and microvascular resistance. Conditions such as dia-
etes, ventricular hypertrophy, and age can all affect CFR
ndependent of the degree of epicardial coronary artery
tenosis (40–43). The concept of relative CFR has been
ntroduced to overcome some of the limitations associated
ith CFR in assessment of epicardial coronary artery
tenosis. Relative CFR is obtained by dividing the CFR of
he reference vessel by the CFR obtained in an adjacent
normal” coronary vessel. This requires interrogation of an
dditional coronary vessel (44).
Because of the limitations in interpretation of CFR and
elative CFR, neither of these modalities has gained wide-
pread acceptance, and these techniques have been sup-
lanted by the use of FFR.
FR
ne method of overcoming the limitations of coronary
ngiography is the use of invasive physiologic testing by the
FR technique to assess the functional significance of a
oronary stenosis. The FFR is defined as the ratio of
aximal blood flow achievable in a stenotic coronary artery
elative to the maximal flow in the same vessel if it were
ormal (45–47) (Fig. 2). A 0.014-inch pressure sensor-
ipped coronary angioplasty guide wire is advanced across a
tenosis, and the absolute distal pressure is recorded at rest
nd at maximal hyperemia induced with intracoronary or
ntravenous infusion of adenosine. Unlike CFR, FFR is
ndependent of changes in heart rate, blood pressure, or
rior infarction, and takes into account the contribution of
ollateral blood flow (46,48).
An FFR value of 0.75 correlates with ischemia on non-
nvasive stress tests (46,47,49,50). Several studies have demon-
Figure 2 Fractional Flow Reserve
A schematic cartoon demonstrating the concept and derivation of fractional
flow reserve (FFR). FFR  (Pd  Pv)/(Pa  Pv). The central venous pressure
approaches 0; therefore, Pv is negligible and FFR  Pd/Pa. Pa  mean
proximal coronary artery pressure; Pd  mean coronary artery pressure distal
to the lesion; Pv  mean central venous pressure.trated that in patients with an intermediate coronary lesion and an FFR 0.75, PCI can safely be deferred (47,51,52).
ardiac event rates are extremely low in this cohort of patients
nd even lower than that predicted if a PCI with a bare metal
tent had been performed owing to the lack of restenosis in the
eferred treatment group (52,53). The FFR is lesion specific
nd can be performed in patients with both single- or multi-
essel CAD (54). Once a PCI is performed, adequacy of the
CI result can be assessed by FFR with established criteria for
successful balloon angioplasty (FFR 0.90) and stent place-
ent (FFR 0.94) (55). Significant abnormal distal coronary
ressure values after stenting predict adverse events at
ollow-up (56,57).
Attaining maximum vasodilation is critical for the accu-
acy of FFR measurement. The lack of a maximum hyper-
mic response produces a lower pressure gradient across the
esion and therefore underestimates its severity (58). There
re various pharmacological agents that include adenosine,
denosine 5’-triphosphate (ATP), papaverine, and dobut-
mine that could be administered intravenously (IV) or
ntracoronary (IC) (59–64). Owing to the low cost and high
afety profile, IC adenosine is used in the majority of FFR
ssessments. However, the assessment of long lesions with
iffuse disease or multiple lesions require a steady state
nduced by either IV adenosine or ATP or IC papaverine for
he pressure pull-back maneuver (62,63).
Studies have shown that occlusion of an epicardial coro-
ary artery leads to perivascular edema and capillary leuko-
yte plugging that prevents full restoration of myocardial
erfusion (65). The FFR is limited in the presence of this
icrovascular dysfunction observed in AMI. In these pa-
ients the FFR is overestimated, given that the ratio is
easured in reference to maximum hyperemia at the level of
he epicardial coronary artery with the assumption that the
icrovasculature is intact.
esion Assessment in Specific Lesion Subsets
eft main coronary artery stenosis. Left main coronary
rtery stenosis, as defined by a diameter stenosis on coronary
ngiography of50%, is found in 5% of diagnostic coronary
ngiograms (66). Assessment of left main CAD can be one
f the most challenging lesion subsets for angiographers. In
he CASS (the Coronary Artery Surgery Study) trial, when
ne observer reported 50% left main coronary artery
tenosis, a second angiographer reported no stenosis 19% of
he time (27).
The FFR has been evaluated in a subset of patients with
eft main coronary artery stenosis. In 1 study, an FFR of
0.75 was associated with excellent 3-year survival and
reedom from major adverse cardiovascular events (MACE)
67). Similarly, a study of 122 patients by Abizaid et al. (68)
emonstrated that patients with a left main minimum
umen diameter (MLD) 3.0 mm determined by IVUS
ad a very low 1-year event rate of 3%. Two recent studies
f ambiguous left main coronary artery stenosis have shown
good correlation between IVUS and FFR in detection
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oronary artery (69,70). A cutoff value of 5.9 mm2 was
ound to correlate best with an FFR of 0.75 (70).
If angioplasty of the left main artery is being considered,
e prefer using IVUS beforehand to assess the anatomy, the
ize of the vessels, and determine whether both left anterior
escending and circumflex ostia are involved. The IVUS
lso reveals the extent of calcification and can be useful in
eciding whether the lesion should be prepared with rota-
ional atherectomy to facilitate placement of the stent.
ssessment of serial stenoses within a single coronary
rtery. Patients with CAD often have multiple stenoses
ithin a single coronary artery, 1 or more of which might be
n intermediate coronary lesion. Both IVUS and FFR can
ssist in the determination of the clinical significance of
ach lesion as well as the optimal treatment strategy.
One study has demonstrated that FFR can accurately
etermine the hemodynamic significance of serial coronary
esions when performed via a slow “pull back method”
uring continuous intravenous infusion of adenosine. The
ndings of the pullback method were validated in the same
tudy when PCI of 1 of the 2 lesions (the more hemody-
amically significant lesion) was performed. The informa-
ion provided could lead to avoidance of unnecessary pro-
edures that increase the restenosis risk without providing a
emodynamic benefit (71).
Intravascular ultrasound also assists in the assessment of
erial stenosis within a single coronary artery. During a
ontinuous mechanical pullback of the IVUS catheter, the
mages provide detailed anatomical information on the
xtent and characteristics of each arterial cross section.
ntravascular ultrasound helps determine which lesions
long the length of the artery are anatomically significant
nd therefore what length of artery needs to be treated with
stent. However, the hemodynamic status along the length
f the artery in question cannot be determined by IVUS
ullback alone.
oronary bypass grafts. By 5 years after coronary artery
ypass graft surgery, vein graft disease affects 48% of grafts
nd 81% at 15 years (72). However, treatment of degener-
ted saphenous vein grafts (SVGs) by PCI is associated with
lower procedural success rate, a higher periprocedural
omplication rate, and a higher restenosis rate (73–76).
Saphenous vein grafts have a different ultrasonographic
ppearance compared with native coronary arteries. There
re no side branches, and veins do not have an EEM;
evertheless, the extent of plaque can be easily identified by
VUS. Perhaps of greater importance, IVUS can character-
ze the quality of the tissue present and determine whether
here is soft mobile material or thrombus in the graft.
owever, some SVG lesions, even in old grafts, might be
brotic and are less likely to embolize when treated with
CI (74). The pathogenesis of vein graft disease has been
lucidated by IVUS (77,78). Early changes of wall thicken-
ng and adaptive remodeling predispose patients to subse-
uent atherosclerosis with occlusive plaque and constrictive (r expansive remodeling (21,77–79). These findings corre-
ate with histopathologic studies and in the future might
stablish windows for potential interventions. Currently,
here are no clinical trials that evaluate the effectiveness of
VUS-guided PCI in patients with SVG disease (78).
Provided the native vessel is occluded proximal to the
nastamosis of the bypass graft, FFR across a bypass graft
tenosis might provide an accurate reflection of the coronary
ow at maximal hyperemia to the distal myocardial bed
upplied by the bypass graft. There is a relative paucity of
ublished reports that assesses the physiological significance
f bypass graft stenoses. Currently, there are no clinical
rials that evaluate the role of FFR in assessing the need for
CI in patients with SVG disease. However, 1 study
valuated Doppler flow velocity and myocardial perfusion
ingle-photon emission computed tomography (SPECT)
ompared with angiography in assessment of SVG stenoses.
lthough there was a poor correlation between angiography
nd either SPECT or CFR, the latter 2 had an excellent
orrelation in the detection of ischemia (83%, kappa 
.61) (80).
ifurcation lesions. Assessment of severity of coronary
tenosis in bifurcation lesions as well as the performance of
CI in bifurcation lesions remains challenging (81–85).
espite the emergence of DES, bifurcation lesions have
higher restenosis rate especially at the ostium of the side
ranch in comparison with simple lesions (85,86). An-
iographic assessment of the severity of bifurcation le-
ions is hampered by the inherent limitations of angiog-
aphy, especially overlap of adjacent vessels, angulation,
nd foreshortening of the origin of the side branch (86).
Intravascular ultrasound can be useful in the assessment
f bifurcation lesions in determining the need for PCI (87).
ntravascular ultrasound can also assist in equipment selec-
ion and planning the PCI approach on the basis of the size
f the vessels and the location of the plaque. It has been
emonstrated that when the “crush technique” is used for
ifurcation stenting, the smallest minimum stent area is
ypically at the ostium of the side branch, which might in
art explain the higher restenosis rate observed at these
ocations (84).
Physiologic determination of the hemodynamic signifi-
ance of bifurcation lesions can also be reliably addressed
ith FFR. Separate FFR analysis of each branch can be
erformed to assess the hemodynamic significance of each
tenosis and provides functional information that corre-
ponds with morphological analysis (86). Koo et al. (88)
valuated the feasibility and safety of physiological assess-
ent of jailed side branches with FFR in 97 patients. The
tudy demonstrated that no lesion with 75% stenosis by
uantitative coronary angiography (QCA) had FFR 0.75
nd among 73 lesions with 75% stenosis only 20 were
unctionally significant (88). Thus, most of the lesions
nvolving the jailed side branch might not have functional
ignificance and do not require revascularization. Ziaee et al.
86) showed that 80% of patients with70% stenosis of the
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Assessment of Intermediate Coronary Lesions February 27, 2007:839–48ide branch had FFR0.75 in their cohort. The use of FFR
n the assessment of bifurcation lesions might prevent
nnecessary interventions in lesions that are not functionally
estrictive. The need for revascularization of the side branch
n bifurcation lesions can be guided by hemodynamic
arameters as determined by FFR.
cute coronary syndromes (ACS). Although FFR pro-
ides critical physiological assessment of coronary artery
tenosis in patients with stable CAD, limited data are
vailable on the utility of FFR in lesion assessment in
atients with ACS. Fractional flow reserve should not be
sed in the acute phase of an AMI due to severe microvas-
ular impairment (58). However, FFR still has a critical role
n the assessment of the non–infarct-related arteries. Pres-
ure readings are only useful after the culprit artery has been
tabilized. Recently, Tamita et al. (89) assessed the utility
nd anatomic correlation of FFR in 33 patients with AMI
hat underwent successful coronary stenting in comparison
ith 15 patients with stable angina. The study demon-
trated no significant correlation between FFR and IVUS in
MI patients with Thrombolysis In Myocardial Infarction
TIMI) flow grades 2 or 3. An FFR 0.94 was observed in
ll TIMI flow grade 2 cases independent of residual steno-
is, and there was a significant increase in FFR in the TIMI
ow grade 2 group in comparison with stable CAD or
IMI flow grade 3 patients (p  0.02). The authors
oncluded that severe microvascular dysfunction that occurs
n AMI causes FFR to greatly underestimate the pressure
radient across a potential flow-limiting lesion. Muramatsu
90) used FFR0.94 in 40 patients with AMI to determine
he effectiveness of FFR-guided stenting. The results
howed no significant difference in the reocclusion rates or
ong-term survival in FFR-guided versus the direct stenting
roup. There was a significant decrease in the number of
alloons used and total cost of hospital stay in the FFR-
uided group versus the direct stenting controls.
The FFR is still useful in lesion assessment in patients
ith previous MI. Claeys et al. (91) showed that FFR is
alsely increased by approximately 5% in patients with
icrovascular dysfunction. De Bruyne et al. (92) deter-
ined that FFR assessments are valid in detecting ischemia
n patients 6 days after an MI. Usui et al. (93) demonstrated
hat FFR assessment of coronary stenosis in patients with
revious MI had a sensitivity and specificity of 79% in
omparison with thallium-201 imaging. A recent study by
otvin et al. (94) evaluated the safety of FFR 0.75 in
eferring PCI in 124 patients with unstable angina, non–
T-segment elevation myocardial infarction, or recent ST-
egment elevation myocardial infarction. At mean follow-up
f 11 months, event-free survival was 89% in the ACS
roup. There was no significant difference in MACE in
atients with stable CAD and ACS that did not undergo
evascularization on the basis of FFR 0.75. These results
ere similar to data presented by Legalery et al. (95) that
ound a 10% event rate in a group of 75 patients with ACS
reated medically on the basis of FFR 0.80. Leesar et al. p50) randomized 70 patients with ACS and moderate
tenosis on angiography to decisions based on FFR versus
yocardial scintigraphy and found that there was no sig-
ificant difference between the 2 modalities in the frequency
f event rates at 1-year. Another 2 observational studies that
ncluded a total of 42 patients with unstable angina or MI
howed an 11% event rate at 1-year (96,97). These studies
emonstrated the utility of FFR in deferring PCI in
on–flow-limiting lesions in patients with ACS and avoid-
ng unnecessary interventions that have a higher complica-
ion rate in these patients. Although there are no large
andomized, controlled trials that have established the
fficacy of FFR in patients with ACS, observational data
escribed previously demonstrate that FFR provides com-
lementary functional information that could be used in
linical decision-making in patients with ACS.
Intravascular ultrasound can also be performed safely in
he setting of AMI (29). Intravascular ultrasound can
dentify anatomically significant lesions, delineate extent of
laque burden, identify ulcerated or ruptured plaque, assess
or presence and extent of intracoronary thrombus, distin-
uish arterial dissection from thrombosis, and assist in
election and sizing of equipment for performance of
oronary intervention. Another important potential appli-
ation of IVUS is identification of atheroma at risk for
upture on the basis of the echolucency, lipid-laden plaque,
nd expansive remodeling observed in ACS (32). Hasegawa
t al. (98) evaluated 73 patients with AMI with preinter-
ention IVUS to further delineate the properties of unstable
laque. The group found that 55% of patients demonstrated
xpansive remodeling and 25% showed constrictive remod-
ling. A previous study by von Birgelen et al. (99) also
evealed a predominance of expansive remodeling and soft
laque in patients with ACS. Although IVUS has expanded
he clinical understanding of the pathogenesis of atheroscle-
osis in stable and unstable plaque, a limited number of
tudies have evaluated the role of IVUS is directing inter-
entions in patients with AMI. One study demonstrated
hat conservative treatment in 17 patients with AMI and
onsignificant lesions by IVUS despite evidence of plaque
upture was associated with a very low incidence of MACE
t 1 year (100). Rioufol et al. (101) evaluated 14 patients
iagnosed with ACS that were found to have a total of 28
uptured plaques without critical stenoses in a nonculprit
oronary artery on IVUS. The patients were treated medi-
ally and followed for a mean of 22 months. There were no
ignificant cardiovascular events related to the lesion at
ollow-up, and 14 of 28 ruptured plaques healed with
edical therapy. Another study conducted a subset analysis
f 42 patients with unstable angina, showing that the
resence of plaque ruptures on IVUS corresponded to
levated levels of creatine kinase (CK)-MB and increased
ates of MACE (cardiac death, Q-wave MI, and target
esion revascularization) at 1-year follow-up (102). Intravas-
ular ultrasound provides critical information regarding the
athogenesis of atherosclerosis, plaque remodeling, and has
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atients with ACS.
The no-reflow phenomenon, defined by the acute reduc-
ion in coronary flow in the setting of a patent epicardial
oronary artery is an uncommon complication of PCI (0.6%
o 2.0%) (103). More frequently, it occurs during rotational
therectomy, interventions involving SVGs, and AMI
103). Up to 30% of PCIs performed in the setting of AMI
re complicated by the “no-reflow” phenomenon where no
lood flow proceeds distally despite a successful balloon
ilatation or stent insertion (104,105). Although, the pre-
ise pathophysiology of no-reflow is still uncertain, various
echanisms, including microvascular spasms, distal embo-
ization of thrombus or atherosclerotic debris, oxygen-free
adical-mediated endothelial injury, or capillary inflamma-
ory injury have been proposed (103). Intravascular ultra-
ound can predict lesions at higher risk for “no-reflow” after
CI, owing to the plaque mass and loose tissue components
f the plaque (105). In addition, IVUS can rule out other
auses of poor flow after PCI such as coronary dissection or
esidual stenosis (106).
stial lesions. Analogous to assessment of lesion severity
n bifurcation stenoses, assessment of ostial lesion severity is
onfounded by vessel overlap with the aorta, angulation, and
eep seating of the catheter beyond the ostial lesion (107).
n a study of 46 patients where 55 ostial lesions were
valuated, 20 of 25 patients (80%) determined to have
tenosis severity of 70% or greater had an FFR 0.75 (86).
lthough sensitivity of angiography in this study was 100%,
he specificity was only 55%; there was an excellent corre-
ation between presence of ischemia by noninvasive stress
maging studies and FFR.
Intravascular ultrasound is also helpful for diagnosing and
reating ostial lesions. Intravascular ultrasound can delineate
he extent of stenosis as well as the plaque burden at the
stial location, although heavy calcification limits the pen-
tration of the ultrasound images. Precise placement of the
tent at the aorta-ostial juncture is often challenging when
sing fluoroscopic guidance. The corresponding position of
he IVUS catheter on the fluoroscopic image at the cross
ection where the ostium is observed on the ultrasound
mage can be very useful in ensuring correct stent placement.
ithout moving the image intensifier, the stent is placed in
he same position as the IVUS catheter was when the
orta-ostial juncture was seen by ultrasound. After PCI,
VUS is helpful to confirm that the entire ostium has been
overed by the stent, which will decrease the chance of
estenosis.
omparison of IVUS and FFR
lthough IVUS does not provide direct estimation of the
emodynamic severity of a coronary lesion, several studies
ave demonstrated a strong correlation between anatomic
ata obtained from IVUS and ischemia by myocardial
erfusion SPECT imaging (108), CFR (109), and FFR p110,111). Briguori et al. (111) evaluated 53 lesions in 43
atients with both IVUS and FFR. Receiver operating
haracteristic curve analysis demonstrated that the following
VUS parameters correlated with an abnormal FFR value
0.75) (in order of decreasing sensitivity and specificity):
70% area stenosis, minimal lumen diameter 1.8 mm,
inimal lumen cross-sectional area 4.0 mm2, and lesion
ength 10 mm. Another study by Takagi et al. (110)
valuated 51 lesions in 42 patients with both FFR and
VUS. Intravascular ultrasound parameters that best corre-
ated with an FFR value 0.75 were 60% area stenosis
nd a minimal lumen cross-sectional area 3.0 mm2. By
roviding precise information on vessel size, extent of the
therosclerosis, and plaque characteristics, IVUS images
elp guide PCI strategy, equipment selection, and assess-
ent of the adequacy of the results.
Fractional flow reserve provides important physiologic
nformation on the hemodynamic severity of a coronary
esion and is helpful in the cardiac catheterization laboratory
o determine whether PCI should be performed without
topping the procedure and sending the patient for a
oninvasive stress test. Fractional flow reserve is easy to
erform and provides an accurate and lesion-specific index
f functional severity of coronary stenosis that correlates
ith noninvasive tests of myocardial ischemia in patients
ith intermediate lesions (112). Fractional flow reserve has
een compared with IVUS as a measurement for optimal
tent deployment. One retrospective analysis showed that
FR 0.94 after stent deployment had a concordance rate
f 91% with IVUS and displayed accuracy in guiding stent
eployment (55). However, another study revealed that
FR 0.96 did not reliably predict an optimum stent result
113). The correlation between adverse outcomes after
ngioplasty and stenting and the FFR index has been
valuated. Bech et al. (114), in 60 patients, showed excellent
linical outcomes at 2 years in patients with diameter
tenosis 35%, and FFR 0.90. Pijls et al. (56) showed
hat a post-stent FFR 0.90 was associated with low
ncidence of the composite end point of death, MI, or total
essel revascularization at 6 months.
The heterogeneity of the patients studied in the multiple
egistries and differences in methodology between studies
reate difficulty in evaluating the efficacy of IVUS and FFR
n specific clinical settings. There are no randomized,
ontrolled trials to demonstrate the superiority of FFR
ersus IVUS in providing improved clinical outcomes in
omparison with angiography alone. However, the issue of
uperiority might be irrelevant, because IVUS and FFR are
omplementary techniques that are used in the catheteriza-
ion laboratory to provide critical anatomic and functional
ata that permit more accurate decisions in the management
f the patient. In our laboratory, both methods are used:
FR is preferred to identify whether an intermediate lesion
s functionally significant, and IVUS is preferred when
ssessing the anatomy of a lesion for sizing, position of
laque, and adequacy of stent deployment.
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oth FFR and IVUS imaging add important functional and
natomic information to augment the luminal images pro-
ided by coronary angiography. Fractional flow reserve and
VUS help identify intermediate lesions that require inter-
ention and reduce unnecessary procedures with potential
omplications. Although FFR and IVUS have eloquent
roponents for either technique, both procedures are valu-
ble in the cardiac catheterization laboratory and provide
ritical information that supplements the foundation of
igh-quality angiography.
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